Tuberculosis - Annual Epidemiological Report for 2019
In 2019, 29 countries in the European Union/European Economic Area (EU/EEA) reported a total of 49 752 tuberculosis (TB) cases (9.6 per 100 000 population). The overall TB notification rate in the EU/EEA continued to decline, as did most country-specific TB notification rates. However, the EU/EEA is not on track to reach the goal of ending the TB epidemic by 2030.
Multidrug resistance (MDR) was reported for 3.4% of TB cases with drug susceptibility testing results reported. Extensive drug resistance (XDR) was reported for 22.4% of MDR TB cases that underwent second-line drug susceptibility testing.
Nineteen countries reported HIV status for 78.0% of their TB cases. Of these TB cases with known HIV status, 3.1% were HIV positive.
Treatment success was achieved in 63.7% of TB cases notified in 2018, 54.9% of HIV-co-infected TB cases notified in 2018, 46.8% of MDR TB cases notified in 2017 and 34.9% of XDR TB cases notified in 2016.
Latest annual epidemiological reports
Tuberculosis (TB) is a serious infectious disease that can be fatal. It most commonly affects the lungs.Read more
Surveillance and disease data for tuberculosis
Together with the World Health Organization’s Regional Office for Europe, ECDC collects and disseminates TB surveillance data for the European region.Read more
All annual Epidemiological Reports (AERs)
The Annual Epidemiological Reports (AERs) are key ECDC publication on the epidemiology of communicable diseases of public health significance in Europe. These reports give overviews of the epidemiology of communicable diseases of public health significance in Europe, drawn from surveillance information on the 52 communicable diseases and health issues for which surveillance is mandatory in the European Union (EU) and European Economic Area (EEA) countries.Read more